SNPHF
Price:
$10.15
Market Cap:
$548.35B
Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that is in Phase III clinical trial. In addition, the company provides DE-114A to treat allergic conjunctivitis; DE-076C for the treatment of vernal keratoconjunctivitis; and DE-109, which is in Phase III clinical trial to treat uveitis. Further, it offe...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2010-06-09
Stock Exchange
PNK
Ticker
SNPHF
According to Santen Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 8.82%. This represents a change of 299.96% compared to the average of 2.20% of the last 4 quarters.
The mean historical ROE of Santen Pharmaceutical Co., Ltd. over the last ten years is 8.55%. The current 8.82% ROE has changed 3.13% with respect to the historical average. Over the past ten years (40 quarters), SNPHF's ROE was at its highest in in the September 2015 quarter at 14.39%. The ROE was at its lowest in in the September 2022 quarter at -9.26%.
Average
8.55%
Median
8.64%
Minimum
-5.08%
Maximum
20.53%
Discovering the peaks and valleys of Santen Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 263.20%
Maximum Annual ROE = 20.53%
Minimum Annual Increase = -271.20%
Minimum Annual ROE = -5.08%
Year | ROE | Change |
---|---|---|
2024 | 8.70% | -271.20% |
2023 | -5.08% | -163.05% |
2022 | 8.06% | 263.20% |
2021 | 2.22% | -71.53% |
2020 | 7.80% | -29.01% |
2019 | 10.98% | -10.96% |
2018 | 12.34% | 43.71% |
2017 | 8.58% | -58.18% |
2016 | 20.53% | 80.89% |
2015 | 11.35% | 4.28% |
The current ROE of Santen Pharmaceutical Co., Ltd. (SNPHF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.90%
5-year avg
4.34%
10-year avg
8.55%
Santen Pharmaceutical Co., Ltd.’s ROE is less than Ono Pharmaceutical Co., Ltd. (15.28%), less than GSK plc (18.08%), less than Grifols, S.A. (3.18%), less than Pfizer Inc. (4.72%),
Company | ROE | Market cap |
---|---|---|
15.28% | $5.27B | |
18.08% | $67.83B | |
3.18% | $6.98B | |
4.72% | $145.36B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santen Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Santen Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Santen Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Santen Pharmaceutical Co., Ltd. (SNPHF)?
What is the highest ROE for Santen Pharmaceutical Co., Ltd. (SNPHF)?
What is the 3-year average ROE for Santen Pharmaceutical Co., Ltd. (SNPHF)?
What is the 5-year average ROE for Santen Pharmaceutical Co., Ltd. (SNPHF)?
How does the current ROE for Santen Pharmaceutical Co., Ltd. (SNPHF) compare to its historical average?